Pediatric COVID-19 Therapeutics: Seizing the Right Research and Development Opportunities to Accelerate Access for Children.
Pediatr Infect Dis J
; 41(1): e1-e5, 2022 01 01.
Article
em En
| MEDLINE
| ID: mdl-34784302
ABSTRACT
Children, although at lower risk of poor outcomes from COVID-19 relative to adults, still stand to benefit from therapeutic interventions. Understanding of COVID-19 clinical presentation and prognosis in children is essential to optimize therapeutic trials design. This perspective illustrates how to collectively accelerate pediatric COVID-19 therapeutic research and development, based on the experience of the Global Accelerator for Paediatric Formulations.
Texto completo:
1
Coleções:
01-internacional
Temas:
Acesso_medicamentos_insumos_estrategicos
Base de dados:
MEDLINE
Assunto principal:
Pesquisa
/
Convulsões
/
Tratamento Farmacológico da COVID-19
Tipo de estudo:
Prognostic_studies
Limite:
Child
/
Humans
Idioma:
En
Revista:
Pediatr Infect Dis J
Ano de publicação:
2022
Tipo de documento:
Article